Press release
Benign Prostatic Hyperplasia (BPH) Drugs Market Drivers, Restraints, Demands, Type and Leading Players - Eli Lilly, GlaxoSmithKline, Astellas Pharma, Sanofi
Benign Prostatic Hyperplasia (BPH) Drugs Market research report makes use of SWOT analysis and Porter’s Five Forces analysis to disclose the strengths, weaknesses, opportunities, and threats in the Pharmaceuticals industry. Analysis and discussion of important industry trends, market size, market share estimates are also covered in this persuasive market report. The report gives out the CAGR value fluctuation during the forecast period of 2022-2028 for the market. The Benign Prostatic Hyperplasia (BPH) Drugs Market report studies various inhibitors as well as motivators of the market in both quantitative and qualitative manner so that users can have perfect information.Request for FREE Sample Report: To Know the Impact of COVID-19 on this Industry at: https://www.reportsnreports.com/contacts/requestsample.aspx?name=5274170
As the global economy mends, the 2021 growth of Benign Prostatic Hyperplasia (BPH) Drugs will have significant change from previous year. According to our (LP Information) latest study, the global Benign Prostatic Hyperplasia (BPH) Drugs market size is USD million in 2022 from USD 3257.1 million in 2021, with a change of % between 2021 and 2022. The global Benign Prostatic Hyperplasia (BPH) Drugs market size will reach USD 4122.5 million in 2028, growing at a CAGR of 3.4% over the analysis period.
The United States Benign Prostatic Hyperplasia (BPH) Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Benign Prostatic Hyperplasia (BPH) Drugs market, reaching US$ million by the year 2028. As for the Europe Benign Prostatic Hyperplasia (BPH) Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Benign Prostatic Hyperplasia (BPH) Drugs players cover Eli Lilly, GlaxoSmithKline, Astellas Pharma, and Sanofi, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Benign Prostatic Hyperplasia (BPH) Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
- Alpha-Blocker
- Phosphodiesterase Type-5 Inhibitors
- Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
- Hospitals
- Drugstores
- Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
- Eli Lilly
- GlaxoSmithKline
- Astellas Pharma
- Sanofi
- Pfizer
- Abbott
- Allergan
- TEVA
- Mylan
- Novartis
- Merck
Purchase this report (FLAT 20% Discount. Coupon Code: JAN20) at: https://www.reportsnreports.com/purchase.aspx?name=5274170
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Benign Prostatic Hyperplasia (BPH) Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Benign Prostatic Hyperplasia (BPH) Drugs by Country/Region, 2017, 2022 & 2028
2.2 Benign Prostatic Hyperplasia (BPH) Drugs Segment by Type
2.2.1 Alpha-Blocker
2.2.2 Phosphodiesterase Type-5 Inhibitors
2.2.3 Others
2.3 Benign Prostatic Hyperplasia (BPH) Drugs Sales by Type
2.3.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Benign Prostatic Hyperplasia (BPH) Drugs Sale Price by Type (2017-2022)
2.4 Benign Prostatic Hyperplasia (BPH) Drugs Segment by Application
2.4.1 Hospitals
2.4.2 Drugstores
2.4.3 Others
2.5 Benign Prostatic Hyperplasia (BPH) Drugs Sales by Application
2.5.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Benign Prostatic Hyperplasia (BPH) Drugs Sale Price by Application (2017-2022)
3 Global Benign Prostatic Hyperplasia (BPH) Drugs by Company
3.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Breakdown Data by Company
3.1.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Share by Company (2020-2022)
3.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue by Company (2020-2022)
3.2.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Benign Prostatic Hyperplasia (BPH) Drugs Sale Price by Company
3.4 Key Manufacturers Benign Prostatic Hyperplasia (BPH) Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Benign Prostatic Hyperplasia (BPH) Drugs Product Location Distribution
3.4.2 Players Benign Prostatic Hyperplasia (BPH) Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Benign Prostatic Hyperplasia (BPH) Drugs by Geographic Region
4.1 World Historic Benign Prostatic Hyperplasia (BPH) Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Annual Revenue by Geographic Region
4.2 World Historic Benign Prostatic Hyperplasia (BPH) Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Annual Revenue by Country/Region
4.3 Americas Benign Prostatic Hyperplasia (BPH) Drugs Sales Growth
4.4 APAC Benign Prostatic Hyperplasia (BPH) Drugs Sales Growth
4.5 Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales Growth
4.6 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Drugs Sales Growth
5 Americas
5.1 Americas Benign Prostatic Hyperplasia (BPH) Drugs Sales by Country
5.1.1 Americas Benign Prostatic Hyperplasia (BPH) Drugs Sales by Country (2017-2022)
5.1.2 Americas Benign Prostatic Hyperplasia (BPH) Drugs Revenue by Country (2017-2022)
5.2 Americas Benign Prostatic Hyperplasia (BPH) Drugs Sales by Type
5.3 Americas Benign Prostatic Hyperplasia (BPH) Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Benign Prostatic Hyperplasia (BPH) Drugs Sales by Region
6.1.1 APAC Benign Prostatic Hyperplasia (BPH) Drugs Sales by Region (2017-2022)
6.1.2 APAC Benign Prostatic Hyperplasia (BPH) Drugs Revenue by Region (2017-2022)
6.2 APAC Benign Prostatic Hyperplasia (BPH) Drugs Sales by Type
6.3 APAC Benign Prostatic Hyperplasia (BPH) Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Benign Prostatic Hyperplasia (BPH) Drugs by Country
7.1.1 Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales by Country (2017-2022)
7.1.2 Europe Benign Prostatic Hyperplasia (BPH) Drugs Revenue by Country (2017-2022)
7.2 Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales by Type
7.3 Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Drugs by Country
8.1.1 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Drugs Sales by Type
8.3 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Benign Prostatic Hyperplasia (BPH) Drugs
10.3 Manufacturing Process Analysis of Benign Prostatic Hyperplasia (BPH) Drugs
10.4 Industry Chain Structure of Benign Prostatic Hyperplasia (BPH) Drugs
11 Marketing, Distributors and Customer
Request for FREE PDF Sample Report at: https://www.reportsnreports.com/contacts/requestsample.aspx?name=5274170
Contact Us:
Corporate Headquarters
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India
+ 1 888 391 5441
sales@reportsandreports.com
About Us:
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Benign Prostatic Hyperplasia (BPH) Drugs Market Drivers, Restraints, Demands, Type and Leading Players - Eli Lilly, GlaxoSmithKline, Astellas Pharma, Sanofi here
News-ID: 2523855 • Views: …
More Releases from ReportsnReports
DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices
Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact!
Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices.
Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register
MarketsandMarkets presents…
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH.
This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the…
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays.
Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/
This conference aims to bring together all the stakeholders to discuss the obstacles in achieving…
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying…
More Releases for Drugs
Generic Drugs Market Application Anti-Infective Drugs, Anti-Arthritis Drugs, Ant …
Generic drugs are the medications that are developed to be similar to a medicine that is already commercially available in the market with a brand name. The generic drug is similar to the medicine available in terms of dosage, safety and strength, mode of administration, quality and intended use. Due to the similarities, generic drugs are capable of treating various diseases. Generic drugs are most cost effective than the branded…
Cytotoxic Drugs Market Growing Demand for Antimetabolite Drugs
According to Precision Business Insights (PBI), the latest report, the cytotoxic drugs market is expected to be valued at USD 15,927.2 million in 2022 and is poised to grow at a significant CAGR of 2.2% over 2022-2028. The primary drivers of the expansion of the global cytotoxic drugs market include the increasing prevalence of cancer diseases, the increasing use and approval of cytotoxic drugs, and the increasing consumption of alcohol…
Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market.
Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market
Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest…
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information:
https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html
Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$…
